Newsletter Subject

Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Jul 5, 2024 08:06 PM

Email Preheader Text

Oncology Update Friday, July 05, 2024 ADVERTISEMENT Exclusives & Features Industry Clinic Ad Insight

[MEDPAGE TODAY]( Oncology Update Friday, July 05, 2024 [Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT]( [More Data Link Obesity to Better Survival for Cancer Patients on Immunotherapy]( [Vapers May Be Less Likely to Undergo Lung Cancer Screening]( [Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer]( [Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma]( ADVERTISEMENT Exclusives & Features [Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?]( Industry Clinic Ad Insights [What Will It Take to Deliver Both Health & Care in Oncology?]( [Tackling Hard-To-Treat Tumors]( A novel antibody may boost antitumor responses in treatment-resistant solid tumors, according to early clinical trial results. [READ MORE]( [A Pipeline for the Automatic Identification of Randomized Controlled Oncology Trials and Assignment of Tumor Entities Using Natural Language Processing]( Background: Most tools trying to automatically extract information from medical publications are domain agnostic and process publications from any field. However, only retrieving trials from... [READ MORE]( [Molecular tumor board: molecularly adjusted therapy upon identification and functional validation of a novel ALK resistance mutation in a case of lung adenocarcinoma.]( We report a case of a long-term surviving patient with EML4/ALK translocated non-small cell adenocarcinoma of the lung in UICC8 stage IVA. During recurrence under continuous crizotinib therapy, a... [READ MORE]( [SerpinB2 deficiency is associated with delayed mammary tumor development and decreased pro-tumorigenic macrophage polarization.]( The in vivo functions of SerpinB2 in tumor cells and tumor-associated macrophages (TAMs) during breast cancer development and metastasis remain elusive. SerpinB2-deficient MMTV-PyMT mice (PyMTSB2-/-)... [READ MORE]( [Geometry based gene expression signatures detect cancer treatment responders in clinical trials]( Aim: The overall aim of this project is to determine if gene expression signatures of tumors, constructed from geometrical attributes of data, could be used to predict patient treatment response by... [READ MORE]( [A Property of Everyday Health group]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2024-07-05&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.